Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/KINTARA-THERAPEUTICS-INC-58136318/news/Kintara-Announces-First-International-Site-Activation-in-GCAR-Phase-2-3-Clinical-Trial-for-Glioblast-37180218/?utm_source=whatsapp&utm_medium=social&utm_campaign=share